Report - Leukemia Committee Agenda - SWOG 2002/Leukemia.pdfDr. Schiffer Proposed Studies S0106 TMA Phase III Study of Gemtuzumab Ozogamicin (Mylotarg) as Post-Consolidation Therapy for Patients

Please pass captcha verification before submit form